The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer

Author：                                

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|5|2107-2115

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.5, 2015-01, pp. : 2107-2115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenovirusmediated overexpression of cystic fibrosis transmembrane conductance regulator enhances invasiveness and motility of serous ovarian cancer cells

By            

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 265-272

Spandidos Publications

Access to resources Recommend Favorite

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer

By Zhang Cong   Ye Leiguang   Guan Songlei   Jin Shunzi   Wang Weili   Sun Shilong   Lee Kuang-Hui   Wei Jun   Liu Baogang  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2047-2051

Springer Publishing Company

Access to resources Recommend Favorite

Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer

By            

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2283-2288

Spandidos Publications

Access to resources Recommend Favorite

Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis

By Samara Katerina D.   Antoniou Katerina M.   Karagiannis Konstantinos   Margaritopoulos Georgios   Lasithiotaki Ismini   Koutala Eleni   Siafakas Nikolaos M.  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1397-1404

Spandidos Publications

Access to resources Recommend Favorite

Medical Management of Non-small Cell Lung Cancer

By Smith I.E.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 818-819

Elsevier

Access to resources Recommend Favorite